26.11.2012 Views

Peptide-Based Drug Design

Peptide-Based Drug Design

Peptide-Based Drug Design

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Analysis of Aβ Interactions 83<br />

2. Incubate the samples for 5 min with agitation to allow the peptide to bind to the<br />

lipid layer (see Note 12).<br />

3. To remove nonspecifically bound protein, wash arrays twice with PB for 2 min,<br />

followed by two 1-min washes with 1 mM HEPES, pH 7.2.<br />

4. Allow the arrays to air-dry for approx 10 min and load l �L of 50% CHCA. Once<br />

the arrays are dry, load another application of l �L of 50% CHCA and dry again.<br />

5. Collect data at low and high molecular weight range.<br />

6. Export data into an Excel spread sheet and determine the lipid binding affinity of<br />

the oligomers by assessing the signal-to-noise/area under the curve (see Note 11).<br />

7. See Fig. 3 for a summary of the A� lipid-binding assay.<br />

4. Notes<br />

1. It is advantageous to initially screen all the available chip types, including PS10,<br />

PS20, RS100, and PG20, to determine which array provides the highest degree<br />

of sensitivity.<br />

2. To assess the purity and quality of the Ab intended for use on preactivated arrays,<br />

screen the Ab on NP20 arrays (normal phase arrays); also refer to the product<br />

data sheet for the presence of carrier proteins such as BSA and gelatin.<br />

3. The binding affinity of Protein G to Ab is species and isotype dependent; rabbit,<br />

goat, and bovine pAb all exhibit high affinity and hence are the preferred Ab<br />

for PG20 arrays. Mouse monoclonal Ab (mAb) IgG1, a common mAb isotype,<br />

exhibits low binding affinity to Protein G and is not recommended.<br />

4. Allow the binding interaction to reach equilibrium (minimum of 30–60 min).<br />

This will minimize differences in the intensity and peak number among the replicates,<br />

improving reproducibility.<br />

5. If nonspecific binding is obscuring A� detection, consider increasing the (1)<br />

wash time, (2) number of washes, (3) wash volume by using a bioprocessor, or<br />

(4) concentration of detergent/salts. Alternatively, detergent/salt can be added to<br />

the sample during the Ag-binding step.<br />

6. A final 1mM HEPES, pH 7.2 wash is performed to remove contaminants such as<br />

salts and detergent, which may interfere with interpretation of spectra. Formation<br />

of salt adducts creates additional peaks with a mass shift of 22 and 38 Da<br />

for sodium and potassium, respectively, which can affect the sensitivity of the<br />

assay. Detergents generate a series of low molecular weight peaks, which can<br />

complicate analysis and decrease the specific signal.<br />

7. Do not allow extended drying time (>20 min) as this can significantly reduce the<br />

reproducibility of the assay.<br />

8. As EAM addition requires working with low volumes, it is critical to use a<br />

well-calibrated 2-�L pipet. Further to this, it is essential to be consistent as the<br />

application of EAM and drying time affect crystallization and hence the signal<br />

intensity.<br />

9. It is advantageous to have two data acquisition settings: one for the low molecular<br />

weight range (0–20 kDa) and the other for the high molecular weight range

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!